North Carolina Reports Dramatic 34% Decline in Overdose Deaths as Settlement Funds Transform Treatment Landscape

Governor Josh Stein stood before recovering individuals and healthcare workers at Hope Haven in Charlotte on Monday, delivering news that would have seemed improbable just a few years ago: North Carolina had achieved a 34% reduction in overdose deaths over the past year, the sharpest single-year decline since 2019 and among the steepest drops recorded anywhere in the United States during the ongoing fentanyl crisis.

The announcement, delivered at a substance abuse rehabilitation center that has served Mecklenburg County for nearly five decades, marked a pivotal moment in the state's battle against opioid addiction. For a state that had watched overdose deaths climb steadily through the pandemic years, the reversal represents not merely a statistical improvement but evidence that sustained public health investment can bend the trajectory of the deadliest drug crisis in American history.

From Litigation to Lifelines

Stein's presence at Hope Haven carried symbolic weight beyond the announcement itself. As North Carolina's former Attorney General, he had led the multistate litigation that secured more than $55 billion from opioid manufacturers, distributors, and pharmacies nationally, with nearly $1.6 billion directed to North Carolina communities. What once seemed like abstract legal victory has, in the intervening years, translated into tangible infrastructure: treatment beds, mobile outreach units, recovery housing, and the medication-assisted treatment programs that Stein and public health officials credit with driving the mortality reduction.

"Every life we lose to an overdose is one life too many," Stein said, flanked by Hope Haven CEO Anthony T. Jones and Mecklenburg County health officials. "We've made progress working in a bipartisan way to treat addiction here in North Carolina, and I thank organizations like Hope Haven that are doing that work."

Hope Haven exemplifies the transformation that settlement funds have enabled. The Charlotte-based therapeutic community has expanded services using opioid settlement allocations, adding residential capacity, workforce development programming, and long-term recovery support that extends far beyond the initial detoxification period. For a population that often cycles through emergency departments and jails without achieving stability, the comprehensive approach—combining housing support, parenting education, and evidence-based counseling—addresses the social determinants that frequently undermine recovery.

The Numbers Behind the Decline

The 34% reduction, reported by the North Carolina Department of Health and Human Services in late April, arrives as welcome news in a state that had experienced six consecutive years of rising overdose mortality. While officials caution that a single year's data does not constitute victory, the magnitude of the decline suggests systemic factors rather than statistical noise.

Public health experts point to several interconnected developments that likely contributed to the improvement. Expanded access to medication-assisted treatment, including buprenorphine and methadone, has reached previously underserved counties through mobile units and telehealth expansion. Naloxone distribution programs, funded through settlement allocations, have equipped first responders, family members, and people who use drugs with the overdose reversal medication that can mean the difference between life and death during the critical minutes following an overdose event.

The settlement framework itself may have played a role beyond the dollars it delivered. North Carolina's approach to fund distribution has drawn national attention for its transparency and accountability mechanisms. Rather than allowing settlement money to disappear into general budgets, the state established clear guidelines requiring evidence-based deployment and regular reporting on outcomes. Counties must demonstrate that funds support treatment, prevention, harm reduction, or recovery services—categories explicitly defined in settlement agreements to prevent the diversion that has plagued other states.

Geographic Equity and Persistent Challenges

Despite the encouraging statewide figures, the distribution of progress remains uneven. Rural counties, particularly in western North Carolina and parts of the coastal plain, continue to face acute treatment access barriers. Transportation limitations, workforce shortages in addiction medicine, and the stigma that persists in smaller communities all complicate efforts to replicate Charlotte's success in more isolated areas.

In January, Stein visited Clay County, a rural jurisdiction in the state's western mountains, to highlight how settlement funds there had supported additional health department staff and outreach efforts targeting residents who might otherwise lack access to services. The contrast between urban and rural implementation illustrates both the potential and the limitations of the settlement model: while money flows to all jurisdictions, capacity to deploy it effectively varies dramatically.

Dr. Kimberly Scott, Mecklenburg County's Interim Public Health Director, acknowledged this disparity while emphasizing the progress achieved. "Mecklenburg County's opioid settlement programs are helping us respond quickly and strategically to our community's needs," she said. "We remain focused on ensuring every resident has access to timely, equitable, and reliable care and support."

Policy Proposals and the Road Ahead

Stein's recommended budget for Fiscal Year 2026-2027 includes provisions designed to build upon the recent gains. The proposal would expand medication-assisted treatment within correctional institutions, addressing a critical transition point where individuals leaving incarceration face elevated overdose risk due to reduced tolerance. The budget also envisions creation of a Fentanyl Control Unit within state law enforcement, reflecting Stein's dual emphasis on treatment expansion and supply reduction.

The proposed Fentanyl Control Unit represents a recognition that demand-side interventions, however necessary, cannot alone address a crisis fueled by synthetic opioids manufactured abroad and distributed through increasingly sophisticated trafficking networks. Mexican cartels, primarily the Sinaloa and Jalisco New Generation organizations, have established North Carolina as a significant distribution hub, with fentanyl appearing not only in counterfeit prescription pills but also mixed into supplies of cocaine, methamphetamine, and heroin—often without users' knowledge.

A National Model?

North Carolina's experience offers potential lessons for other states grappling with similar challenges. The combination of substantial settlement resources, relatively transparent allocation mechanisms, and sustained political commitment across administrations has created conditions for measurable improvement. Whether this model can be replicated elsewhere depends on factors beyond funding alone: the quality of existing treatment infrastructure, the capacity of local health departments, and the willingness of policymakers to prioritize evidence-based approaches over ideological preferences.

The state's approach also highlights the long-term nature of the challenge. Settlement funds, while substantial, represent a time-limited resource distributed over 15 to 18 years. Sustaining the progress achieved during the initial investment phase will require either continued public funding commitments or fundamental restructuring of how addiction treatment is financed and delivered.

For the individuals in recovery at Hope Haven and similar facilities across North Carolina, the statistical decline translates into lived reality: parents reunited with children, stable housing secured, employment obtained. These individual stories, multiplied thousands of times, constitute the true measure of success—one that no percentage point can fully capture, but that the recent data suggests is increasingly within reach.

As Stein concluded his remarks in Charlotte, the message was clear: the 34% decline represents not an endpoint but a foundation. The opioid crisis, fueled by synthetic drugs that evolve faster than regulatory frameworks can adapt, will require sustained attention and investment for years to come. But for the first time in nearly a decade, North Carolina has demonstrated that the trajectory can bend—that with sufficient resources, political will, and community partnership, the deadliest public health crisis in a generation can be confronted effectively.